- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
7
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
7 companies
PharmaResearch
Market Cap: ₩4.6t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩442,000.00
7D
13.0%
1Y
-37.2%
JW Pharmaceutical
Market Cap: ₩625.5b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩27,400.00
7D
3.4%
1Y
26.9%
JW Holdings
Market Cap: ₩281.6b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,070.00
7D
2.4%
1Y
23.5%
Samsung BiologicsLtd
Market Cap: ₩73.9t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,599,000.00
7D
3.6%
1Y
2.0%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩35,900.00
7D
-5.8%
1Y
-3.0%
JW Shinyak
Market Cap: ₩111.4b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,993.00
7D
-7.3%
1Y
41.1%
SK Biopharmaceuticals
Market Cap: ₩7.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩91,600.00
7D
7.4%
1Y
-9.1%